Sadagatullah A N, Sahadun Maa, Md-Isa M K, Yusof M F
Department of Orthopaedics, Universiti Sains Malaysia, Kubang Kerian, Malaysia.
Department of Orthopaedics, Hospital Melaka, Melaka, Malaysia.
Malays Orthop J. 2025 Mar;19(1):49-56. doi: 10.5704/MOJ.2503.007.
Total knee replacement (TKR) is a highly effective treatment for end-stage knee osteoarthritis and has been proven to have excellent results in relieving pain as well as improving mobility of the patient. Although becoming more increasingly performed, it is still associated with considerable perioperative blood loss requiring allogenic blood transfusion. Allogenic blood transfusion (ABT) can be lifesaving in certain clinical situations but also comes with their own risks and side effects. The reported incidence of ABT and blood loss following TKR surgery varies widely in the literature. The objectives of this study were to look at the prevalence of ABT, factors leading to transfusion as well as increase in blood loss.
A cross-sectional retrospective study was conducted involving 296 adult patients who underwent elective primary unilateral TKR surgery from January 2015 until December 2019 at Hospital Melaka. Medical records of these patients were reviewed, and relevant data were extracted for final analysis. Incidence of ABT, demographic data, use of antiplatelet/anticoagulant, tourniquet time, types of general anaesthesia, and pre- and post-operative haemoglobin count were recorded. These factors were analysed to look at the association with ABT as well as increase in blood loss.
Prevalence of ABT following primary unilateral TKR surgery were found to be 4.39% (95% confidence interval 2.04, 6.74). Pre-operative haemoglobin value was found to be the only significant variable associated with blood transfusion [P<0.001; Odds ratio (OR) = 0.35; 95% Confidence interval (CI) 0.22, 0.54]. Meanwhile, prolonged tourniquet time of >120 minutes was the only significant variable towards an increase in blood loss. Participants with tourniquet time >120 minutes has 2.67 times the odds to have blood loss >2 g/dL compared to participants with tourniquet time of less or equal to 120 minutes (95% CI=1.54, 4.64).
The prevalence of ABT following primary unilateral TKR was lower in our centre compared to other reported studies. Pre-operative optimisation of anaemic patients with haematinics will help surgeons reduce the need for ABT.
全膝关节置换术(TKR)是治疗终末期膝骨关节炎的一种高效疗法,已被证明在缓解疼痛以及改善患者活动能力方面效果显著。尽管该手术的实施越来越多,但仍伴有大量围手术期失血,需要异体输血。异体输血(ABT)在某些临床情况下可能挽救生命,但也有其自身的风险和副作用。文献中报道的TKR手术后ABT和失血的发生率差异很大。本研究的目的是了解ABT的发生率、导致输血的因素以及失血量的增加情况。
进行了一项横断面回顾性研究,纳入了2015年1月至2019年12月在马六甲医院接受择期初次单侧TKR手术的296例成年患者。查阅了这些患者的病历,并提取相关数据进行最终分析。记录了ABT的发生率、人口统计学数据、抗血小板/抗凝剂的使用情况、止血带时间、全身麻醉类型以及术前和术后血红蛋白计数。分析这些因素与ABT以及失血量增加之间的关联。
初次单侧TKR手术后ABT的发生率为4.39%(95%置信区间2.04,6.74)。术前血红蛋白值是与输血相关的唯一显著变量[P<0.001;比值比(OR)=0.35;95%置信区间(CI)0.22,0.54]。同时,止血带时间延长至>120分钟是导致失血量增加的唯一显著变量。与止血带时间小于或等于120分钟的参与者相比,止血带时间>120分钟的参与者失血量>2 g/dL的几率高2.67倍(95% CI=1.54,4.64)。
与其他报道的研究相比,我们中心初次单侧TKR后ABT的发生率较低。术前用补血药优化贫血患者的状况将有助于外科医生减少ABT的需求。